Iovance Biotherapeutics, Inc. (IOVA)
7.63
-0.46
(-5.69%)
USD |
NASDAQ |
Nov 12, 16:00
7.63
0.00 (0.00%)
After-Hours: 07:52
Iovance Biotherapeutics EPS Diluted (Quarterly) : -0.0488 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.0488 |
| June 30, 2026 | -0.1051 |
| March 31, 2026 | -0.1889 |
| December 31, 2025 | -0.1767 |
| September 30, 2025 | -0.2507 |
| June 30, 2025 | -0.3338 |
| March 31, 2025 | -0.3598 |
| December 31, 2024 | -0.2577 |
| September 30, 2024 | -0.2755 |
| June 30, 2024 | -0.3409 |
| March 31, 2024 | -0.4244 |
| December 31, 2023 | -0.4547 |
| September 30, 2023 | -0.4628 |
| June 30, 2023 | -0.4746 |
| March 31, 2023 | -0.5024 |
| December 31, 2022 | -0.6392 |
| September 30, 2022 | -0.6312 |
| June 30, 2022 | -0.6317 |
| March 31, 2022 | -0.5831 |
| December 31, 2021 | -0.633 |
| September 30, 2021 | -0.5538 |
| June 30, 2021 | -0.5291 |
| March 31, 2021 | -0.512 |
| December 31, 2020 | -0.4661 |
| September 30, 2020 | -0.3998 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.4732 |
| March 31, 2020 | -0.5499 |
| December 31, 2019 | -0.5034 |
| September 30, 2019 | -0.399 |
| June 30, 2019 | -0.3848 |
| March 31, 2019 | -0.2994 |
| December 31, 2018 | -0.2735 |
| September 30, 2018 | -0.3558 |
| June 30, 2018 | -0.34 |
| March 31, 2018 | -0.3143 |
| December 31, 2017 | -0.36 |
| September 30, 2017 | -0.35 |
| June 30, 2017 | -0.37 |
| March 31, 2017 | -0.33 |
| December 31, 2016 | -0.25 |
| September 30, 2016 | -1.15 |
| June 30, 2016 | -0.23 |
| March 31, 2016 | -0.14 |
| December 31, 2015 | -0.20 |
| September 30, 2015 | -0.16 |
| June 30, 2015 | -0.14 |
| March 31, 2015 | -0.14 |
| December 31, 2014 | -0.1442 |
| September 30, 2014 | -0.11 |
| June 30, 2014 | -0.09 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AVITA Medical, Inc. | -0.2016 |
| Halozyme Therapeutics, Inc. | 2.015 |
| CareDx, Inc. | 0.3509 |
| Merck & Co., Inc. | 2.044 |
| SELLAS Life Sciences Group, Inc. | -0.0508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -22.27M |
| Revenue (Quarterly) | 121.47M |
| Total Expenses (Quarterly) | 143.74M |
| Enterprise Value | 3.198B |
| Gross Profit Margin (Quarterly) | 52.64% |
| Profit Margin (Quarterly) | -18.33% |
| Earnings Yield | -6.81% |
| Normalized Earnings Yield | -6.809 |